ENTITY
SMARTSCORE: 2.8/5
Dexcom Inc

Dexcom Inc (DXCM US)

49
Analysis
Health CareUnited States
DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.
more
29 May 2025 17:24Issuer-paid

KDST + NLSP Combined Core Investment Case 29052025

We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of...

Logo
234 Views
Share
13 Mar 2025 16:29Issuer-paid

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innovation 13032025

Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge.

Logo
182 Views
Share
27 Aug 2024 11:54Issuer-paid

Biopharma Week in Review - Aug 26, 2024

Last week, BVNRY ramped up its mpox vaccine supply, as the first case in Asia popped up and a possible US case of this year’s global health emergency.

Logo
141 Views
Share
x